| Profile | GDS1873 / 217731_s_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 405.78 | 72 |
| GSM40788 | control - Rep 2 | 364.492 | 70 |
| GSM40789 | control - Rep 3 | 318.896 | 67 |
| GSM40775 | androgen treated - Rep 1 | 349.84 | 69 |
| GSM40776 | androgen treated - Rep 2 | 303.192 | 65 |
| GSM40777 | androgen treated - Rep 3 | 297.728 | 65 |
| GSM40790 | estrogen treated - Rep 1 | 339.928 | 68 |
| GSM40791 | estrogen treated - Rep 2 | 449.44 | 74 |
| GSM40792 | estrogen treated - Rep 3 | 340.721 | 68 |
| GSM40784 | A + tamoxifen - Rep 1 | 410.474 | 72 |
| GSM40785 | A + tamoxifen - Rep 2 | 377.443 | 71 |
| GSM40786 | A + tamoxifen - Rep 3 | 331.767 | 68 |
| GSM40778 | A + anastrozole - Rep 1 | 302.6 | 66 |
| GSM40779 | A + anastrozole - Rep 2 | 464.05 | 74 |
| GSM40780 | A + anastrozole - Rep 3 | 263.795 | 62 |
| GSM40781 | A + letrozole - Rep 1 | 235.11 | 59 |
| GSM40782 | A + letrozole - Rep 2 | 364.593 | 69 |
| GSM40783 | A + letrozole - Rep 3 | 475.557 | 76 |